Skip to content

Clinical trials

Terminated Phase 1/2 Lymphoma, B-Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell Phase: Phase 1/2 Status: Terminated Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20131
20142
20152
20171
20181
20191
20224
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alopexx Oncology, LLC2
Aegera Therapeutics1
Asana BioSciences1
BioNova Pharmaceuticals (Shanghai) LTD.1
Brian Hill1
CRISPR Therapeutics AG1
Dynavax Technologies Corporation1
Gamida Cell ltd1
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell16
Lymphoma10
Lymphoma, Non-Hodgkin9
Lymphoma, Large B-Cell, Diffuse8
Lymphoma, Mantle-Cell6
Leukemia, Lymphocytic, Chronic, B-Cell5
Lymphoma, Follicular5
Recurrence4
Burkitt Lymphoma3
Leukemia3

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.